Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis
Alimentary Pharmacology and Therapeutics, 08/20/09
Gasche C et al. – In the set of biopsies taken from patients treated with 1.5 g 5–ASA for 1 year, there was no improvement in the prevalence of MSI in the distal colon.
Related Articles
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 70%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 69%
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09
Relevance Score: 68%
Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 68%
Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of appendicectomy in the subsequent development of inflammatory bowel disease: a UK-based study
International Journal of Colorectal Disease, 12/18/09
Delayed Colonic Perforation after ESD in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
The Internet Journal of Gastroenterology, 12/18/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
New modalities and paradigms for sedation: new sedation agents
Techniques in Gastrointestinal Endoscopy , 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


